Ori Biotech

About:

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments.

Website: https://oribiotech.com/

Twitter/X: oribiotech

Top Investors: Octopus Ventures, Amadeus Capital Partners, Puhua Capital, Northpond Ventures, Kindred Capital

Description:

Ori Biotech is a developer of a manufacturing platform used to help patients get access to lifesaving treatments. Ori has developed a proprietary, flexible manufacturing platform that closes, automates, and standardizes manufacturing allowing therapeutics developers to further develop and bring their products from pre-clinical process development to commercial-scale manufacturing. The company aims to speed up the innovation of cell and gene therapies through the manufacturing platform it is bringing to market.

Total Funding Amount:

$139M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2015-01-01

Founders:

Chris Mason, Farlan Veraitch

Number of Employees:

11-50

Last Funding Date:

2022-01-18

IPO Status:

Private

Industries:

© 2025 bioDAO.ai